Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance

Pediatric Diabetes

Volumn 17, Issue 1, 2016, Pages 53-60

  Wu, Shimin ^a   Gao, Hongjie ^a   Ma, Yumei ^a   Fu, Lina ^a   Zhang, Cai ^a   Luo, Xiaoping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adolescent; Betatrophin; Children; Insulin resistance; Obesity; Overweight

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; BETATROPHIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; INSULIN; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ADOLESCENT; ADOLESCENT OBESITY; ARTICLE; BODY MASS; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; METABOLISM; OBESITY; PRESCHOOL CHILD;

ADOLESCENT; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OVERWEIGHT; PEDIATRIC OBESITY; PEPTIDE HORMONES;

EID: 84953262017     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12233     Document Type: Article

References (44)

1. Jung C, Figulla HR, Lichtenauer M, Franz M, Pernow J. Increased levels of circulating arginase I in overweight compared to normal weight adolescents. Pediatr Diabetes 2014: 15: 51-56.
2. Cunningham SA, Kramer MR, Narayan KM. Incidence of childhood obesity in the United States. N Engl J Med 2014: 370: 403-411.
3. Weiss R, Dziura J, Burgert TS et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004: 350: 2362-2374.
4. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005: 146: 693-700.
5. Ramkumar S, Tandon N. Type 2 diabetes mellitus in children and youth. Indian J Pediatr 2013: 80 (Suppl. 1): S87-S94.
6. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001: 7: 941-946.
7. Lee P, Linderman JD, Smith S et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab 2014: 19: 302-309.
8. Peng Y, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 2013: 153: 747-758.
9. Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 2012: 303: 334-351.
10. Fu Z, Yao F, Abou-Samra AB, Zhang R. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem Biophys Res Commun 2013: 430: 1126-1131.
11. Zhang R, Abou-Samra AB. Emerging roles of Lipasin as a critical lipid regulator. Biochem Biophys Res Commun 2013: 432: 401-405.
12. Wang Y, Quagliarini F, Gusarova V et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A 2013: 110: 16109-16114.
13. Yang J, Le Lay J, Yu M, Naji A, Kaestner KH. Elevated mouse hepatic betatrophin expression does not increase human beta-cell replication in the transplant setting. Diabetes 2014: 63: 1283-1288.
14. Fenzl A, Itariu BK, Kosi L et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 2014: 57: 1204-1208.
15. Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep 2014: 4: 5013.
16. Gomez-Ambrosi J, Pascual E, Catalan V et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab 2014: 99: E2004-E2009.
17. Espes D, Martinell M, Carlsson PO. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014: 2014: 323407.
18. Hu H, Sun W, Yu S et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 2014: 37: 2718-2722.
19. Li H, Ji CY, Zong XN, Zhang YQ. Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years. Chin J Pediatr 2009: 47: 493-498.
20. Brown RJ, Yanovski JA. Estimation of insulin sensitivity in children: methods, measures and controversies. Pediatr Diabetes 2014: 15: 151-161.
21. Xi B, Zhao X, Shen Y et al. An obesity genetic risk score predicts risk of insulin resistance among Chinese children. Endocrine 2014. [Epub ahead of print].
22. Nysom K, Molgaard C, Hutchings B, Michaelsen KF. Body mass index of 0 to 45-y-old Danes: reference values and comparison with published European reference values. Int J Obes (Lond) 2001: 25: 177-184.
23. Espes D, Lau J, Carlsson PO. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 2014: 57: 50-53.
24. Monteiro PA, Antunes Bde M, Silveira LS, Christofaro DG, Fernandes RA, Freitas Junior IF. Body composition variables as predictors of NAFLD by ultrasound in obese children and adolescents. BMC Pediatr 2014: 14: 25.
25. Lakshman REC, Ong KK. Childhood obesity. Circulation 2012: 126: 1770-1779.
26. Fagot-Campagna A, Engelgau MM, Burrows NR et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000: 136: 664-672.
27. Reinehr T. Type 2 diabetes mellitus in children and adolescents. World J Diabetes 2013: 4: 270-281.
28. Springer SC, Silverstein J, Copeland K et al. Management of type 2 diabetes mellitus in children and adolescents. Pediatrics 2013: 131: 648-664.
29. Zeitler P, Fu J, Tandon N et al. Type 2 diabetes in the child and adolescent. Pediatr Diabetes 2014: 15 (Suppl. 20): 26-46.
30. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 2012: 424: 786-792.
31. Fu Z, Abou-Samra AB, Zhang R. An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia 2014: 57: 2232-2234.
32. Liu Q, Bengmark S, Qu S. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis 2010: 9: 42.
33. Manti S, Romano C, Chirico V et al. Nonalcoholic fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". Hepat Mon 2014: 14: e17641.
34. Park MH, Falconer C, Viner RM, Kinra S. The impact of childhood obesity on morbidity and mortality in adulthood: a systematic review. Obes Rev 2012: 13: 985-1000.
35. Liu L, Mei M, Yang S, Li Q. Roles of chronic low-grade inflammation in the development of ectopic fat deposition. Mediators Inflamm 2014: 2014: 418185.
36. Lettner A, Roden M. Ectopic fat and insulin resistance. Curr Diab Rep 2008: 8: 185-191.
37. Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 2004: 28 (Suppl. 4): S12-S21.
38. Nguyen P, Leray V, Diez M et al. Liver lipid metabolism. J Anim Physiol Anim Nutr 2008: 92: 272-283.
39. Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: disparate associations among Asian populations. World J Hepatol 2014: 6: 263-273.
40. Marzuillo P, Del Giudice EM, Santoro N. Pediatric non-alcoholic fatty liver disease: new insights and future directions. World J Hepatol 2014: 6: 217-225.
41. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006: 118: 1388-1393.
42. Smith SR, Lovejoy JC, Greenway F et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001: 50: 425-435.
43. Kindblom JM, Lorentzon M, Hellqvist A et al. BMI changes during childhood and adolescence as predictors of amount of adult subcutaneous and visceral adipose tissue in men: the GOOD Study. Diabetes 2009: 58: 867-874.
44. Wen X, Kleinman K, Gillman MW, Rifas-Shiman SL, Taveras EM. Childhood body mass index trajectories: modeling, characterizing, pairwise correlations and socio-demographic predictors of trajectory characteristics. BMC Med Res Methodol 2012: 12: 38.